Cargando…
Treatment of obstructive jaundice induced by non-hodgkin lymphoma with EUS-guided transgastric anterograde common bile duct stenting: Technical case report and literature review
BACKGROUND: Non-Hodgkin lymphoma (NHL) is a rare cause of biliary obstruction. The optimum treatment for these patients is unclear. Lymphoma-associated obstructive jaundice is generally managed with open surgery, Endoscopic retrograde cholangiopancreatography (ERCP), or Percutaneous transhepatic bil...
Autores principales: | Yuan, Lingzhi, Shi, Xiao, Shan, Hongbo, Xiao, Dinghua, Wang, Xiaoyan, Wang, Fen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9852524/ https://www.ncbi.nlm.nih.gov/pubmed/36684212 http://dx.doi.org/10.3389/fsurg.2022.1031718 |
Ejemplares similares
-
EUS-directed transgastric ERCP
por: Mendoza Ladd, Antonio
Publicado: (2018) -
Multicenter retrospective cohort of EUS-guided anterograde pancreatic duct access
por: Motomura, Douglas, et al.
Publicado: (2023) -
Vanishing bile duct syndrome-related jaundice as the first presentation of Hodgkin lymphoma
por: Mellat-Ardakani, Milad, et al.
Publicado: (2023) -
An adverse event of EUS-directed transgastric ERCP: stent-in-stent technique to bridge the peritoneal gap
por: Duloy, Anna, et al.
Publicado: (2019) -
The Management of an Intraperitoneal Leak Following Transgastric Stenting of a Pancreatic Pseudocyst
por: Mimery, Alexander, et al.
Publicado: (2020)